Abstract
Background
Hispanic/Latinx males and those who are non-English proficient are significantly less likely to receive germline genetic evaluation for prostate cancer. Undertesting can impact downstream outcomes, including reduced access to approved targeted therapies, barriers to precision medicine trials, and hereditary cancer assessment for patients and family members. The goal of our study was to explore the knowledge and perceptions of genetic testing among U.S. Hispanic males, with the ultimate goal to identify potentially actionable targets to increase guideline-concordant genetic evaluation.
Methods
We conducted a nationwide online survey including U.S. Hispanic males aged ≥ 40 in English and Spanish using the 9-item Knowledge of Hereditary Prostate Cancer Scale and adapted questions about desire for more information from the Behavioral Beliefs about BRCA Genetic Counseling scale.
Results
Among 807 participants, the mean score for genetic knowledge was 5.8 out of 9, with gaps in understanding of incomplete penetrance of genes and maternal genetic inheritance. Medical mistrust and lower health literacy were associated with significantly lower knowledge of prostate cancer genetics. Overall, attitudes toward genetic counseling were favorable, with the majority of participants endorsing that it would help with decision-making, is concordant with cultural beliefs, and that they were interested in more information. Concerns about genetic evaluation included cost and impact for insurance.
Conclusions
Despite generally favorable attitudes toward genetic evaluation among Hispanic males, there are important knowledge gaps, including the importance of both maternal and paternal family history, as well as logistical concerns. Addressing these gaps through culturally targeted outreach may help to promote equitable uptake of germline genetic evaluation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data are available for health/medical/biomedical research purposes. Interested investigators are required to submit a formal letter of intent outlining research aims, rationale, and approach, along with documentation of local IRB approval. A Data Use Agreement must be signed by the institutions involved before any data is released.
References
Lichtensztajn DY, Leppert JT, Brooks JD, Shah SA, Sieh W, Chung BI, et al. Undertreatment of high-risk localized prostate cancer in the California Latino population. J Natl Compr Cancer Netw. 2018;16:1353–60.
Kwon DH, Borno HT, Cheng HH, Zhou AY, Small EJ. Ethnic disparities among men with prostate cancer undergoing germline testing. Urol Oncol. 2020;38:80 e1–7.
Swami N, Baez YA, Franco I, Nguyen T, Meiyappan K, Ton M, et al. Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer Prostatic Dis. 2022;26:309-16.
Kurian AW, Abrahamse P, Furgal A, Ward KC, Hamilton AS, Hodan R, et al. Germline genetic testing after cancer diagnosis. Jama. 2023;330:43–51.
Borno HT, Odisho AY, Gunn CM, Pankowska M, Rider JR. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer. Urol Oncol. 2021;39:233 e9–14.
Soewito S, Wyatt R, Berenson E, Poullard N, Gessay S, Mette L, et al. Disparities in cancer genetic testing and variants of uncertain significance in the Hispanic population of South Texas. JCO Oncol Pract. 2022;18:e805–e13.
Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psychooncology. 2013;22:1594–604.
Vadaparampil ST, McIntyre J, Quinn GP. Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity. J Genet Couns. 2010;19:618–29.
Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, et al. Genomic disparities in breast cancer among Latinas. Cancer Control. 2016;23:359–72.
Loeb S, Ravenell JE, Gomez SL, Borno HT, Siu K, Sanchez Nolasco T, et al. The effect of racial concordance on patient trust in online videos about prostate cancer: a randomized clinical trial. JAMA Netw Open. 2023;6:e2324395.
Marin G, Sabogal F, Marin BV, Otero-Sabogal R, Perez-Stable EJ. Development of a short acculturation scale for Hispanics. Hispanic J Behav Sci. 1987;9:183–205.
Steidel AGL, Contreras JM. A new familism scale for use with Latino populations. Hispanic J Behav Sci. 2003;25:312–30.
Sarkar U, Schillinger D, Lopez A, Sudore R. Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. J Gen Intern Med. 2011;26:265–71.
Norman CD, Skinner HA. eHEALS: the eHealth literacy scale. J Med Internet Res. 2006;8:e27.
Aponte J, Nokes KM. Electronic health literacy of older Hispanics with diabetes. Health Promot Int. 2017;32:482–9.
Paramio Pérez G, Almagro BJ, Hernando Gómez Á, Aguaded Gómez JI. Validación de la escala eHealth Literacy (eHEALS) en población universitaria española. Revista Esp de Salud Pública. 2015;89:329–38.
Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38:209–18.
Martinez B, Huh J, Tsui J. Validating the group-based medical mistrust scale with English and Spanish-speaking Latino parents of adolescents. J Am Board Fam Med. 2022;35:244–54.
Weinrich S, Vijayakumar S, Powell IJ, Priest J, Hamner CA, McCloud L, et al. Knowledge of hereditary prostate cancer among high-risk African American men. Oncol Nurs Forum. 2007;34:854–60.
Vadaparampil ST, Quinn GP, Small BJ, McIntyre J, Loi CA, Closser Z, et al. A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer. Genet Test Mol Biomark. 2010;14:99–106.
National Cancer Institute Health Information National Trends Survey. https://hints.cancer.gov/. Accessed July 14, 2019.
National Cancer Institute. Encuesta Nacional de Tendencias Sobre Información de la Salud. https://hints.cancer.gov/docs/Instruments/HINTS5_Cycle4_AnnotatedInstrumentSpanish.pdf. Accessed July 23, 2022.
Rivera Rivera JN, Conley CC, Castro-Figueroa EM, Moreno L, Dutil J, García JD, et al. Behavioral beliefs about genetic counseling among high-risk Latina breast cancer survivors in Florida and Puerto Rico. Cancer Med. 2023;12:4701–6.
Loeb S, Sanchez Nolasco T, Siu K, Byrne N, Giri VN. Usefulness of podcasts to provide public education on prostate cancer genetics. Prostate Cancer Prostatic Dis. 2023;26:772–77.
Feldman EA. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine. J Gen Intern Med. 2012;27:743–6.
Pew Research Center. A look at small businesses in the U.S. https://www.pewresearch.org/short-reads/2024/04/22/a-look-at-small-businesses-in-the-us/. Accessed July 14, 2025.
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, et al. Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020;38:2798–811.
Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, et al. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing. BMC Public Health. 2024;24:2533.
American Community Survey Selected Population Profile in the United States. https://data.census.gov/. Accessed July 14 2025.
Funding
Supported by a grant from the Department of Defense (HT94252311040).
Author information
Authors and Affiliations
Contributions
Conceptualization (SL, VNG, and SV), Project administration (TSN, MRC, and NB), Statistical analysis (AR and MS), Data interpretation (All authors), Writing—original draft (JS and SL), Writing-review and editing (All authors), Funding acquisition (SL, VNG, and SV).
Corresponding author
Ethics declarations
Competing interests
SL reports consulting with Astellas, Blue Earth, Endo, Savor Health, and Doceree, and research funding from Endo, unrelated to current study. VNG reports grant funding from the Department of Defense and Prostate Cancer Foundation; stock ownership in Novopyxis (unrelated to the current study).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saunders, J., Giri, V.N., Vadaparampil, S.T. et al. Knowledge and attitudes toward prostate cancer germline genetic testing among Hispanic males. Prostate Cancer Prostatic Dis (2025). https://doi.org/10.1038/s41391-025-01008-0
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41391-025-01008-0
This article is cited by
-
Best of 2025 in prostate cancer and prostatic diseases
Prostate Cancer and Prostatic Diseases (2026)


